Cargando…
Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?
Autores principales: | Beckebaum, Susanne, Cicinnati, Vito R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010221/ https://www.ncbi.nlm.nih.gov/pubmed/21049289 http://dx.doi.org/10.1007/s10620-010-1449-1 |
Ejemplares similares
-
Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction
por: Wang, Pusen, et al.
Publicado: (2017) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022) -
Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023) -
Hypothyroidism conversion to hyperthyroidism: it’s never too late
por: Ahmad, Ehtasham, et al.
Publicado: (2018) -
Aortic coarctation – never too late to diagnose, never too late to treat
por: Conti, L, et al.
Publicado: (2017)